Old Web
English
Sign In
Acemap
>
authorDetail
>
Kaiyin Fei
Kaiyin Fei
Janssen Pharmaceutica
Medicine
Physical therapy
Golimumab
Rheumatoid arthritis
Placebo-controlled study
3
Papers
10
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
10 Performance of SLEDAI-2K Responder Index-50 in a Randomized Placebo-Controlled Trial with Ustekinumab (UST) in Systemic Lupus Erythematosus
2019
Lupus science & medicine
Zahi Touma
Dafna D. Gladman
Kaiyin Fei
Y Irene Gregan
Robert Gordon
Kim Hung Lo
Shawn Rose
Murray B. Urowitz
Show All
Source
Cite
Save
Citations (0)
Efficacy and safety of golimumab in Indian patients with rheumatoid arthritis: Subgroup data from GO-MORE study.
2016
International Journal of Rheumatic Diseases
Sarvajeet Pal
Sarath Chandra Mouli Veeravalli
Siddharth Kumar Das
Vineeta Shobha
Ramakrishna Rao Uppuluri
Bg Dharmanand
Milind Nadkar
Elizabeth C. Hsia
Kaiyin Fei
R. Yao
Ahmed Khalifa
Show All
Source
Cite
Save
Citations (3)
Efficacy and safety results from a Phase 3, randomized, placebo-controlled trial of subcutaneous golimumab in Chinese patients with active rheumatoid arthritis despite methotrexate therapy.
2016
International Journal of Rheumatic Diseases
Zhanguo Li
Fengchun Zhang
Jonathan Kay
Kaiyin Fei
Chenglong Han
Yanli Zhuang
Zhong Wu
Elizabeth C. Hsia
Show All
Source
Cite
Save
Citations (7)
1